Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biocryst Pharmaceuticals buy Evercore ISI

Biocryst Pharmaceuticals
Start price
€7.73
13.01.25 / 50%
Target price
€11.76
13.01.26
Performance (%)
-25.83%
End price
€5.73
14.01.26
Summary
This prediction ended on 14.01.26 with a price of €5.73. The prediction for Biocryst Pharmaceuticals disappointed with a performance of -25.83%. Evercore_ISI has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Biocryst Pharmaceuticals 1.223% 1.223% 13.653%
iShares Core DAX® 2,57 % 3,50 % 8,41 %
iShares Nasdaq 100 4,86 % 0,65 % 28,38 %
iShares Nikkei 225® 5,59 % -0,25 % 52,92 %
iShares S&P 500 3,25 % 2,08 % 24,37 %

Comments by Evercore_ISI for this prediction

In the thread Biocryst Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -25.83%
Target price 11.765
Change
Ends at 13.01.26

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its price target raised by analysts at Evercore ISI from $10.00 to $12.00. They now have an "outperform" rating on the stock.
Ratings data for BCRX provided by MarketBeat

Evercore ISI 
0
Report Share
13.01.25
In the thread Trading Biocryst Pharmaceuticals
Prediction Buy
Perf. (%) -25.83%
Target price 11.765
Change
Ends at 13.01.26

Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten

Evercore ISI 
0
Report Share
14.01.26

Stopped prediction by Evercore_ISI for Biocryst Pharmaceuticals

buy
Biocryst Pharmaceuticals

Start price
Target price
Perf. (%)
€6.67
20.04.23
€9.11
20.04.24
-38.50%
21.04.24

Evercore ISI 
20.04.23 50%